M1 Kliniken AG Stock
M1 Kliniken AG Stock
The M1 Kliniken AG stock is trending slightly upwards today, with an increase of €0.10 (0.560%) compared to yesterday's price.
So far the community has only identified positive things for M1 Kliniken AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of M1 Kliniken AG in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of M1 Kliniken AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| M1 Kliniken AG | 0.560% | -3.871% | 25.035% | 10.370% | 7.387% | 182.911% | 93.926% |
| Mediclin AG | 1.080% | 9.412% | 3.333% | 48.800% | 56.303% | 8.772% | -1.064% |
| Vita 34 AG | 3.670% | 0.926% | -2.679% | 25.000% | 32.282% | -33.211% | -56.746% |
| Surgery Partners Inc | 4.960% | -1.399% | -22.951% | -32.857% | -28.788% | -40.731% | -37.054% |
News
EQS-News: M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
EQS-News: M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
EQS-News: M1 Kliniken AG: Successful First Half of 2025 with EBIT Growth of 24% and Earnings per Share of EUR 0.63
EQS-News: M1 Kliniken AG: Successful First Half of 2025 with EBIT Growth of 24% and Earnings per Share of EUR 0.63